Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.67
-0.52 (-8.40%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $352.22 million as of October 17, 2025. Its market cap has decreased by -18.76% in one year.
Market Cap
352.22M
Enterprise Value
193.02M
1-Year Change
-18.76%
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $352.22M, a decrease of -11.44%. That is a compound annual growth rate of -3.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 352.22M | -14.22% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |